Bayer raised the objection against Natco’s brand launched under the name Regonat alleging infringement of its patent rights.

Bayer admitted before the court that it has not used its patents for commercial exploitation in India while Ajanta had launched its drug ba...

India remains on Priority Watch List, and continues to be singled out for what the USTR considers to be inadequate protection of intellectu...

And that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global...

Typically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the ...

In India, Bayer sells the product through its equal stake JV Bayer Zydus, formed with Ahmedabad-based Zydus Cadila.

The Delhi High Court has dismissed AstraZeneca’s plea to block Hyderabadbased Lee Pharma from making copies of its anti-diabetes drug Ongly...

With global macro-economic scenario turning volatile, Indian players may have to strategise harder to stay ahead.

DIPP has shot down a health ministry proposal to consider a government-initiated compulsory licence for cancer drug Dasatinib.

A unit of US drugmaker Merck & Co sued India's Glenmark Pharmaceuticals on Tuesday for infringing its patent on two diabetes drugs.

MNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few month...

Several global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India,...

The company has time till January 11 to make change or stop sales of the Microsoft Word software.